In Reply We appreciate the letters from Schepisi et al and Nekhlyudov et al, both of which highlight the need for a definition of cancer survivorship care that goes beyond surveillance for recurrent disease. In our study,1 we reported on the inconsistency and lack of clarity among national guidelines regarding posttreatment surveillance in patients with common adult cancers and recommended a more systematic guideline development process. These letters make an additional point about the appropriate scope of survivorship care.
Merkow RP, Korenstein D, Baxi SS. Consider Quality of Life to Improve Quality of Cancer Guidelines—Reply. JAMA Intern Med. 2017;177(10):1538–1539. doi:10.1001/jamainternmed.2017.3700
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: